
               
               
               CLINICAL PHARMACOLOGY:
               
               
                  
                     
                     
                     
                        Selenium sulfide appears to have a cytostatic effect on cells of the epidermis and follicular epithelium, reducing corneocyte production.
                     
                     
                  
               
               
                  
                     
                     
                     INDICATIONS AND USAGE:
                     
                        For treatment of tinea versicolor, seborrheic dermatitis of scalp and treatment of dandruff.
                     
                     
                  
               
               
                  
                     
                     
                     CONTRAINDICATIONS:
                     
                        Not to be used by patients allergic to any of its ingredients.
                     
                     
                  
               
               
                  
                     
                     
                     PRECAUTIONS:
                     
                     
                        
                           
                           
                           General:
                           
                              Not to be used when acute inflammation or exudation is present as increased absorption may occur.
                           
                           
                        
                     
                     
                        
                           
                           
                           Information for Patients:
                           
                              See Warnings and Precautions section under Application Instructions.
                           
                           
                        
                     
                     
                        
                           
                           
                           Carcinogenesis:
                           
                              Dermal application of 25% and 50% solutions of 2.5% selenium sulfide lotion on mice over an 88 week period, indicated no carcinogenic effects.
                           
                           
                        
                     
                     
                        
                           
                           
                           Pregnancy:
                           
                              WHEN USED ON BODY SURFACES FOR THE TREATMENT OF TINEA VERSICOLOR, SELENIUM SULFIDE LOTION, USP 2.5% IS CLASSIFIED AS PREGNANCY CATEGORY C. Animal reproduction studies have not been conducted with selenium sulfide.  It is also not known whether selenium sulfide can cause fetal harm when applied to body surfaces of a pregnant woman or can affect reproduction capacity.  Under ordinary circumstances selenium sulfide should not be used for the treatment of tinea versicolor in pregnant women.
                           
                           
                        
                     
                     
                        
                           
                           
                           Pediatric Use:
                           
                              Safety and effectiveness in infants have not been established.
                           
                           
                        
                     
                  
               
               
                  
                     
                     
                     ADVERSE REACTIONS:
                     
                        In decreasing order of severity: skin irritation; occasional reports of increase in normal hair loss; discoloration of hair (can be avoided or minimized by thorough rinsing of hair after treatment). As with other shampoos, oiliness or dryness of hair and scalp may occur.
                     
                     
                  
               
            
         